A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder

By Sasson Y.   Iancu I.   Fux M.   Taub M.   Dannon P.N.   Zohar J.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol

By Andrezina Raisa   Josiassen Richard   Marcus Ronald   Oren Dan   Manos George   Stock Elyse   Carson William   Iwamoto Taro  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 281-292

Springer Publishing Company

Access to resources Recommend Favorite

A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder

By Blashko C.A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 258-258

Elsevier

Access to resources Recommend Favorite

A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression

By Hantsoo Liisa   Ward-O’Brien Deborah   Czarkowski Kathryn   Gueorguieva Ralitza   Price Lawrence   Epperson C.  

Psychopharmacology, Vol. 231, Iss. 5, 2014-03 ,pp. : 939-948

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Generalised Anxiety Disorder with Venlafaxine XR: A Randomised, Double-Blind Trial in Comparison with Buspirone and Placebo

By Rolland P.D.  

Clinical Drug Investigation, Vol. 19, Iss. 2, 2000-02 ,pp. : 163-165

Adis International

Access to resources Recommend Favorite